(Q33845203)

29 July 2017

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival (English)

1 reference

29 July 2017

29

Meredith Yeager

0 references

Bas Bueno-de-Mesquita

8

H Bas Bueno-de-Mesquita

1 reference

29 July 2017

5

Demetrius Albanes

1 reference

29 July 2017

7

Heiner Boeing

1 reference

29 July 2017

Saioa Chamosa

10

0 references

Yin Cao

Yin Cao

1

0 references

Federico Canzian

Federico Canzian

9

0 references

Domenico Palli

Domenico Palli

20

0 references

Mattias Johansson

Mattias Johansson

18

0 references

Stephen Chanock

11

Stephen J Chanock

1 reference

29 July 2017

Afshan Siddiq

22

0 references

Dimitris Trichopoulos

27

Dimitrios Trichopoulos

1 reference

29 July 2017

3

Fredrick Schumacher

1 reference

29 July 2017

28

Walter C Willett

1 reference

29 July 2017

Christopher A. Haiman

16

Christopher A Haiman

1 reference

29 July 2017

12

W Ryan Diver

1 reference

29 July 2017

17

Brian Henderson

1 reference

29 July 2017

19

Loïc Le Marchand

1 reference

29 July 2017

21

Bernard Rosner

1 reference

29 July 2017

23

Meir Stampfer

1 reference

29 July 2017

26

Ruth C Travis

1 reference

29 July 2017

15

Edward L Giovannucci

1 reference

29 July 2017

13

Susan M Gapstur

1 reference

29 July 2017

6

Sonja Berndt

1 reference

29 July 2017

4

Victoria L Stevens

1 reference

29 July 2017

25

Rulla Tamimi

1 reference

29 July 2017

33

Xihong Lin

1 reference

29 July 2017

14

J Michael Gaziano

1 reference

29 July 2017

24

Daniel O Stram

1 reference

29 July 2017

31

Ann W Hsing

1 reference

29 July 2017

30

Peter Kraft

1 reference

29 July 2017

2

Sara Lindström

1 reference

29 July 2017

Michael Pollak

32

1 reference

29 July 2017

Jing Ma

34

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2014

1 reference

Journal of the National Cancer Institute

29 July 2017

1 reference

29 July 2017

106

1 reference

29 July 2017

6

1 reference

29 July 2017

dju085

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

29 July 2017

1 reference

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Kernel machine approach to testing the significance of multiple genetic markers for risk prediction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

A Large-scale genetic association study of esophageal adenocarcinoma risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Insulin and insulin-like growth factor signalling in neoplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Peptide receptors as molecular targets for cancer diagnosis and therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Response of patients with advanced prostatic cancer to administration of somatostatin analog RC-160 (vapreotide) at the time of relapse

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081624

High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers

29 October 2018

1 reference

12 December 2020

Insulin-like growth factors and cancer

1 reference

12 December 2020

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

1 reference

12 December 2020

Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238

1 reference

12 December 2020

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

1 reference

12 December 2020

Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU085

1 reference

29 July 2017

1 reference

29 July 2017

1 reference